Pfizer Plans to Seek Booster Approval for 16- and 17-Year-Olds

vaccine

Pfizer and BioNTech plan to apply for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds.



from WebMD Health webmd
If You Enjoyed This, Take 5 Seconds To Share It